Clinical trial
Betaferon/ Betaseron (Interferon Beta-1b) in Patients With Chronic Viral…
NCT00185250 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00185250 |
|---|---|
| Title | Betaferon/ Betaseron (Interferon Beta-1b) in Patients With Chronic Viral Cardiomyopathy |
| Official title | Double-Blind, Placebo-Controlled, Randomized, Parallel Group, Multicenter Study to Evaluate Efficacy and Safety of 4 and 8 Million Units Betaferon®/Betaseron® (Interferon Beta-1b) Given Subcutaneously Every Other Day Over 24 Weeks in Patients With Chronic Viral Cardiomyopathy |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cardiomyopathies, Heart Diseases |
| Intervention type | Drug |
| Interventions | Interferon beta-1b (Betaferon/Betaseron, BAY86-5046), Placebo |
| Enrollment | 138 |
| Start date | Dec 1, 2002 |
| Completion | Nov 1, 2005 |
| First posted | Sep 16, 2005 |
| Last update posted | Dec 19, 2008 |
| Countries | France, Germany, Italy, Poland, Spain, Sweden, United Kingdom |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: